Journal of Renal Nutrition
Volume 21, Issue 2 , Pages 160-168 , March 2011

Relationship Between Beliefs Regarding a Low Salt Diet in Chronic Renal Failure Patients on Dialysis

References 

  1. Romão JE. Doença renal crônica: definição, epidemiologia e classificação. J Bras Nefrol. 2004;26(Suppl 1):1–3
  2. Onuigbo MA. The natural history of chronic kidney disease revisited—a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection. Adv Perit Dial. 2009;25:85–88
  3. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Executive Summary. Available at http://www.kdoqi.org2002;Accessed 20 March 2007
  4. Lindlay EJ. Reducing sodium intake in hemodialysis patients. Semin Dial. 2009;22(3):260–263
  5. Boero R, Pignataro A, Quarello F. Salt intake and kidney disease. J Nephrol. 2002;15:225–229
  6. Campbell WG, Fuad G, Catanzaro DF, et al. Plasma and renal prorenin/renin, renin mRNA, and blood pressure in Dahl salt-sensitive and salt-resistant rats. Hypertension. 1996;27:1121–1133
  7. Chen Y, Oroszi TL, Morris M. Salt consumption increases blood pressure and abolishes the light/dark rhythm in angiotensin AT1a receptor deficient mice. Physiol Behav. 2006;88:95–100
  8. Weir MR, Dworkin LD. Antihypertensive drugs, dietary salt end renal protection: how low should you go and with which therapy?. Am J Kidney Dis. 1998;32:1–22
  9. Heeg JE, de Jong PE, van der Hem GK, et al. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int. 1989;36:272–279
  10. Shaldon S. An explanation for the “lag phenomenon” in drug-free control of hypertension by dietary salt restriction in patients with chronic kidney diseases on hemodialysis. Clin Nephrol. 2006;66:1–2
  11. Twardowski ZJ. Sodium, hypertension and an explanation of the “lag phenomenon” in the hemodialysis patients. Hemodial Int. 2008;12:12–25
  12. Filho AS, Barbosa LF, Andrade DA, et al. Análise da influência do ganho de peso interdialítico sobre a pressão arterial e hipertrofia ventricular esquerda em pacientes sob tratamento hemodialítico. Rev Port Nefrol Hipert. 2004;18:227–233
  13. Sarkar SR, Kotanko P, Levin NW. Interdialytic weight gain: implications in hemodialysis patients. Semin Dial. 2006;19:429–433
  14. Testa A. Relation entre les apports sodés et la prise de poids interdialytique. Nephrol Ther. 2007;3(Suppl 2):S133–S136
  15. Fouque D. Nutritional requirements in maintenance hemodialysis. Adv Ren Replace Ther. 2003;10:183–193
  16. National Kidney Foundation. KDOQI™ Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(Suppl 2):1–180
  17. Chazot C, Collonge C, Charra B. Diététique hypossodée chez le patient dialysé: mythe ou realité?. Nephrol Ther. 2007;3(Suppl 2):S137–S140
  18. Ajzen I. The theory of planned behaviour: organizational behaviour and human decision processes. Psychol Rev. 1991;50:179–211
  19. Fishbein M, Guenther-Grey C, Johnson W, et al. Using a theory-based community intervention to reduce AIDS risk behaviors: the CDC's AIDS community demonstration projects. In:  Oskamp S,  Thompson SC editor. Understanding and Preventing HIV Risk Behaviors: Safer Sex and Drug Use. Thousand Oaks, CA: Sage Publications; 1991;p. 177–206
  20. Conner M, Norman P. Predicting Health Behaviour. London, EG: Open University Press; 2005;
  21. Janz NK, Becker HM. The health belief model: a decade later. Health Educ Q. 1984;11:1–47
  22. Bennett SJ, Milgron LB, Champion V, et al. Beliefs about medication and dietary compliance in people with heart failure: in instrument develop study. Heart Lung. 1997;26:273–279
  23. Bennett SJ, Perkins S, Lane K, et al. Reliability and validity of the compliance belief scales among patients with heart failure. Heart Lung. 2001;30:177–185
  24. In:  Ajzen I,  Fishbein M editor. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ: Prentice-Hall; 1980;
  25. Ferreira MC, Gallani MC. Adaptação transcultural dos instrumentos: BMCS–Beliefs about Medication Compliance Scale e BDCS–Beliefs about Dietary Compliance Scale. Rev Soc Cardiol Estado de São Paulo. 2005;15(Suppl B):116
  26. Ferreira-Sae MC, Gallani MC, Nadruz W, et al. Reliability and validity of a semi-quantitative FFQ for sodium intake in low-income and low-literacy Brazilian hypertensive subjects. Public Health Nutr. 2009;12:2168–2173
  27. Molina MC, Cunha RS, Herkenhoff LF, et al. Hypertension and salt intake in an urban population. Rev Saude Publica. 2003;37:743–750
  28. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88:1338–1346
  29. US Department of Health and Human Services and US Department of Agriculture. Dietary Guidelines for Americans. 6th ed. 2005;Available at http://www.health.gov/dietaryguidelines/dga2005/report/HTML/D7_Fluid.htmAccessed 15 February 2006
  30. Cornélio ME, Gallani MC, Godin G, et al. Development and reliability of an instrument to measure psychosocial determinants of salt consumption among hypertensive patients. Rev Lat Am Enfermagem. 2009;17:710–707
  31. Ajani UA, Dunbar SB, Ford ES, et al. Sodium intake among people with normal and high blood pressure. Am J Prev Med. 2005;29(Suppl 1):63–67
  32. US Department of Health and Human Services. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Available at http://www.nhlbi.nih.gov/guidelines/hypertension2004;Accessed 20 March 2008
  33. Welch JL, Bennett SJ, Delp RL, et al. Benefits of and barriers to dietary sodium adherence. West J Nurs Res. 2006;28:162–180

PII: S1051-2276(10)00078-6

doi: 10.1053/j.jrn.2010.03.007

Journal of Renal Nutrition
Volume 21, Issue 2 , Pages 160-168 , March 2011

Article Tools